Researchers at Hasbro Children's Hospital in Providence, RI have identified a revolutionary new treatment regimen for pediatric Hodgkin's lymphoma, the third most common cancer in children. Led by the director of pediatric hematology/oncology at Hasbro Children's Hospital, Cindy Schwartz, MD, the team of researchers developed a chemotherapy regimen that combined the effectiveness of dose-dense drug delivery with a reduction in long-term risks traditionally presented by high dose chemotherapy.
More >> Revolutionary new treatment regimen identified for pediatric Hodgkin's lymphoma
More >> Revolutionary new treatment regimen identified for pediatric Hodgkin's lymphoma
No comments:
Post a Comment